Brief: Allurion Technologies Says Agence Nationale De Sécurité Du Médicament, French Regulatory Authority, Has Suspended Sales Of Allurion Balloon In France
07/08/2024 23:12
Aug 7 (Reuters) - Allurion Technologies Inc ALUR.N :
* ALLURION TECHNOLOGIES - AGENCE NATIONALE DE SÉCURITÉ DU
MÉDICAMENT, FRENCH REGULATORY AUTHORITY, HAS SUSPENDED SALES OF
ALLURION BALLOON IN FRANCE
* ALLURION TECHNOLOGIES INC - COMPANY IS WITHDRAWING THE
DEVICE
FROM FRENCH MARKET
* ALLURION-COMMITTED TO CONTINUING ENGAGEMENT WITH ANSM TO
IDENTIFY PATH THAT WILL ENABLE CO TO RESUME COMMERCIALIZATION OF
ALLURION BALLOON IN FRANCE
Source text for Eikon: ID:n0000950170-24-093016
Further company coverage: ALUR.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy